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INTRODUCTION
A ge-related macular degeneration (AMD) continues to be the main cause of blindness in adults ≥65-year-old [1] . The development of choroidal neovascularization (CNV) in wet AMD patients usually leads to severe loss of vision. The current medical treatments are designed using the intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) drug, triamcinolone acetonide, photodynamic therapy, or laser photocoagulation on CNV membrane to prevent the progression of AMD [2] . However, if the retinal pigment epithelium (RPE) underlying the fovea is damaged severely, pharmacological treatment exerts limited effects on the bestcorrected visual acuity (BCVA). The occurrence of drusen between Bruch membrane and RPE layer and the formation of CNV are the two pathological characteristics typical of AMD.
Damage of visual function in AMD patients mainly results from the atrophy of RPE layer induced by the deposit of RPE metabolite and macular edema, histological destruction, and retinal hemorrhage due to CNV. The currently clinical therapies, such as photodynamic therapy and submacular surgery, are focused primarily on eliminating CNV [3] [4] [5] .
Mesenchymal stem cells (MSCs) are originated from the embryonic mesoderm during embryonic development. MSCs are limited to bone marrow and adult connective tissues [6] .
Moreover, they can clone and form adherent fibroblastic cells expressing the characteristic properties of cell surface markers. Since the cells are highly proliferative ex vivo and can differentiate along different cell lineages, they are considered as resources for transplantation and stem cell therapy [7] . In addition to soluble factors, exosomes are a sort of extracellular vesicles (EVs) sized approximately 100 nm (range, 30-120 nm) in diameter released from many different types of cells. Unlike other types of EVs, microvesicles (MVs) have different sizes (up to 2 μm) and are produced by various mechanisms [8] . Recent studies have confirmed a novel basis that exosomes may play crucial roles in providing intercellular communication [9] . MSC-derived exosomes (MSCExos) possess similar functions to MSCs. Despite the obvious advantages of MSC transplantation, the issues of allogeneic and heterologous immunological rejection concerns with respect to malignant transformation, and obstruction of small vessels continue to persist. These potential risks may be avoided by exosomes' administration. In addition, owing to the nanometer size, the exosomes can easily traverse the biological barriers and enter the target organs [10] . Previously, we demonstrated that neural stem cells originating from MSCs exhibit a neuroprotective effect by increasing the number of surviving retinal ganglion cells and notably reduce the progression of diabetic retinopathy (DR) [11] . The transplantation of MSC-Exos could be a novel choice for the treatment of AMD. In the present study, we investigated if MSC-Exos could ameliorate the blue light stimulation in RPE cells and retinal laser injury.
MATERIALS AND METHODS Cell Culture and Isolation and Characterization of Exosomes
The study was approved by Tianjin Medical University Medical Ethics Committee and conducted in accordance with the Declaration of Helsinki, including current revisions and with Good Clinical Practice guidelines. We isolated and differentiated the umbilical cord blood mesenchymal stem cells (UCMSCs) according to the previously published protocol [10] . Briefly, the morphology of the human UCMSCs (hUCMSCs) was uniformly spindle-shape with a racial or spiral-shaped arrangement. Flow cytometric studies indicate that the MSCs exhibited a characteristic immune phenotype; CD73, CD90, and CD105 were highly expressed, while CD11b, CD19, CD34, CD45, and HLA-D were weakly expressed. Supernatants of MSCs at passage 3 cultured in fetal bovine serum (FBS)-free medium were centrifuged at 200, 2000, and 10 000 ×g, sequentially, to remove the cells and cell debris, followed by centrifugation at 110 000 ×g for 2h. After washing two times, the pellet was resuspended in PBS. The morphology of exosomes were observed by scanning electron microscopy, and the surface markers of exosomes were identified by proteomic analysis. . The spectral measurements of LED spectra showed a peak wavelength of 448 nm with 2000±500 lx. Subsequently, the cells were treated with radiation from a distance of 35 cm within a cell culture incubator for 12h. In this setting, the cells were exposed to radiation treatment at 0.8 mW/cm 2 as measured using a power meter (Coherent, Santa Clara, CA, USA). The results showed that the radiation treatment did not have any effect on the temperature of the cell medium.
Cell Model Preparation

Real-time Quantitative Polymerase Chain Reaction
Following MSCs-Exos treatment, total RNA was obtained from ARPE-19 cells using RNeasy Micro/Mini Kits (Invitrogen, CA, USA) according to the manufacturer's instructions. mRNA was reverse transcribed (cDNA synthesis) using GoTaq polymerase chain reaction (PCR) master mix (Invitrogen) under the following reaction conditions: 94℃ for 30s, 62℃ for 30s, and 72℃ for 1min. Then, the cDNA was subjected to real-time quantitative PCR using SYBR Green Supermix (Invitrogen) in a Roche 234 Light Cycler 480 PCR System. The primer sequences were as follows: GAPDH: Fwd 5'-ATCCCATCACCATCTTCC-3'; Rev 5'-ATCACGCCACAGTTTCC-3'; VEGFR: Fwd 5'-GGCTGTTCTCGCTTCG-3'; Rev 5'-TGTCCACCAGGG TCTCG-3'. Each sample was analyzed in triplicates, and a cycle threshold (Ct) value of transcripts was determined in the exponential phase using Light Cycler software 4.0. Finally, the fold-change in the mRNA levels was determined by the 2 -△△ Ct method. Immunocytochemistry Immunocytochemistry was performed when the ARPE-19 cells were grown as monolayers on transwell plates. Subsequently, the cells were fixed in 4% paraformaldehyde, washed, and probed with polyclonal antibody to anti-VEGF-A (1:200; Shenyang Wanlei, China) in blocking solution, followed by incubation with secondary antibody. None of the immunohistochemistry experiments The mice were anesthetized by chloral hydrate at 500 mg/kg body weight intraperitoneally, and then, the pupil was dilated with 0.5% tropicamide. A krypton laser (NOVUS OMNI, Coherent, USA; wavelength, 577 nm; power, 200 mW; exposure time, 100ms; diameter, 100 μm) was used to generate 8 laser spots on the left retina of each mouse using glass slide. Each laser spot was distanced >200 μm from others while avoiding the major vessels. For treatment, 5 μL PBS alone, MSCs-Exos at the concentration of 50 μg/mL were intravitreally injected immediately after the laser injury. The right eyes served as normal controls. Histological Analysis The eyes, obtained from the animal models, were fixed, dehydrated, and embedded in paraffin. HE staining and immunohistochemistry were performed on 4 μm-thick serial coronal sections of the retinas. The sections at the centers of laser spots were selected from continuous slices. After antigen retrieval, 5% bovine serum albumin (BSA) was incubated with the slices to block the non-specific binding. The sections were incubated with an antibody against mouse VEGF-A (Shenyang Wanlei, China) according to the manufacturer's instructions. Diaminobenzidine substrate (Zhong Shan Jin Qiao, China) was used for color development following the manufacturer's protocol and observed by light microscopy. The damaged retina was defined as the area in which, the normal cytoarchitectural alters in any retinal layer could be distinguished, according to the method described previously. The quantification of VEGF-A immunostaining was calculated using a computer imaging analysis system as follows: the proportion of the area occupied by the brown staining in the retinal tissue. Fundus Fluorescein Angiography The rats were anesthetized, and injected peritoneally with 10% fluorescein sodium (0.5 mL/kg). Rats were fixed on a slit-lamp delivery system, and the ocular fundus was recorded consecutively by fundus camera system (Zeiss, USA). Fundus fluorescein angiography (FFA) was tested 14d after injection in each experimental group. Statistical Analysis The data were presented as mean±SEM. All experiments were repeated at least three times. The data were compared by one-way ANOVA. P<0.05 was considered statistically significant. All analyses were performed using a statistical software package (SPSS 13.0; SPSS Inc., Chicago, IL, USA).
RESULTS Isolation and Characterization of MSCs-derived Exosomes
Exosomes shed by MSCs were isolated with a series of centrifugation and ultracentrifugation steps. Then, the identity of the exosomes was confirmed by electron microscopy. The exosomes were observed in the extracellular medium of MSCs ( Figure 1 ). The exosomes exhibited the typical characteristic morphology (cup-shaped) and size (diameter between 50 and 150 nm). The exosomes were further characterized by Western blot in the presence of exosomal protein marker, CD63, and the MSC protein marker, CD90 (Figure 2 ). Figure 5 ). These results confirmed that MSCs-Exos comprise the critical mechanism underlying VEGF-A downregulation in the current study.
MSCs-derived Exosomes
Histopathology The structure of retina was continuous with normal capillary structure in the control group ( Figure 6A ). The Bruch membrane and RPE layer were disrupted in the center of laser burns, and the layer of choroid was destroyed within the laser burn 14d post-laser photocoagulation ( Figure 6B ). Retinal edema was found, and newly formed vessels extended from the choroid into the subretinal space 21d after laser photocoagulation ( Figure 6C ). Treatment with MSCs-Exos attenuated the development of CNV 14d after laser photocoagulation ( Figure 6D ). As a result, fibroblasts and collagen fibers were reduced. In addition, large sets of vascular channels were not observed in the subretinal space 21d after laser photocoagulation ( Figure 6E ). The expression of VEGF-A increased gradually in the rats of model group at 14 and 21d post-laser photocoagulation. However, the expression of VEGF-A decreased when treated with MSCs-Exos (P<0.05). The three treated groups (Exo-L, Exo-M, and Exo-H) showed a decreased protein expression of VEGF-A at 14 and 21d after laser photocoagulation. Also, we found that the VEGF-A protein expression in the Exo-H group was significantly lower than that in the other treated groups (t=0.957, 1.382; P<0.05; Table 1 ).
MSCs-derived exosomes downregulate VEGF
Fundus Fluorescein Angiography
The examination of FFA showed large areas of CNV at Bruch membrane rupture sites at 14d after laser photocoagulation ( Figure 7A) . The results indicated a successful establishment of the CNV model. Treatment with MSCs-Exos attenuated the leakages as compared to the model group (Exo-L: 0.346, Exo-M: 3.382, Exo-H: 8.571; P<0.05; Figure 7B -7D). We found that the leakages in the Exo-H group were prominently lower than that in the Exo-L group (5.698, P<0.05). The Exo-H group had a remarkable inhibitory effect on the leakages in all the three treated groups.
DISCUSSION
The present findings indicated that MSCs-Exos ameliorate the blue light stimulation in RPE cells and laser-induced retinal injury via the downregulation of VEGF-A. Considering the physiological function and location, the RPE cells are exposed to a variety of reactive oxygen species (ROS); thus, the protection of RPE cells from light damage may be an ideal strategy for the treatment of AMD [12] . We used blue light to induce VEGF expression in ARPE-19 cells. The blue lightinduced oxidative stress is a typical model that can detect the expression of VEGF in RPE cells sensitively [12] . Moreover, the exposure to light is related to the occurrence and development of AMD putatively through the pathology of VEGF mechanism [13] . Although the blue light illumination induced ROS generation in RPE cells and increased their production in mitochondria, a positive correlation was established between light-induced oxidation and age [14] . Western blot and RT-PCR were employed for the quantification of VEGF expression. We observed that blue light radiation treatment could induce VEGF expression remarkably. These results suggested that blue light could induce VEGF expression in ARPE-19 cells and that it could be used for stimulating the disease model in the current study. Presently, MSCs have become a promising source of stem cell regeneration medicine and are considered superior to other types of stem cells because of convenient isolation, long-term cryopreservation, ex vivo expansion, easy genetic manipulation, and some ethical and legal concerns [15] . Although these cells have been conventionally withdrawn from bone marrow, umbilical cord, and associated tissues, such as artery, umbilical cord vein, and placenta, they have been recently speculated as an alternative source of MSCs [16] . Therefore, hUCMSCs are expected to become cellular candidates for stem cell therapy and transplantation. MSCs are capable of secreting exosomes as reported previously, and exosome markers have been associated with AMD (during the discovery of drusen) [17] . Recent studies have found that several types of cell, including MSCs, can affect the adjacent cells by the release of exosomes [18] . Moreover, the MSCs-Exos seem to reduce the leakage of the vessel in a model of AMD, whereas RPEderived exosomes do not prevent the leakage of new blood vessels [19] . Consecutively, another group showed that MSCsExos could inhibit the neovascularization by inhibiting NF-β signaling [20] . Furthermore, exosomes are known to transfer functional miRNAs, proteins, and mRNAs to recipient cells [21] . The in vitro experiments demonstrated that exosomes harbor the potential to downregulate the expression of VEGF in RPE cells. These results support the critical role of VEGF in the pathogenesis of retina damage, thereby suggesting that MSCExos exert their protective effect via VEGF regulation. The laser-induced retina injury model is widely used in the study of retinal injury. In the current study, the power, wavelength, and exposure time of the laser were controlled to avoid damage to the Bruch membrane. Moreover, eight laser spots were generated on each retina, such that each laser spot was at least two-spot diameters away from the others. The number of laser spots not only made it easier to obtain sufficient histological data from an equivalent number of samples but could also detect the changes in the retinal function based on electroretinogram evaluation. Herein, separate lesions spaced by normal retina could also be observed under the microscope with eight laser spots generated in one mouse eye, indicating that this mouse model was suitable for the study of the retinal injury. Previous studies have shown that laser injury ablates the RPE and causes damage to the photoreceptor, resulting in the release of pro-vascular mediators, such as VEGF [22] [23] . We found that the expression of VEGF was increased at an early stage post-injury, which was strongly inhibited by MSC-Exos, suggesting a key role in the inhibition of VEGF by exosomes. Thus, we speculated that MSC-Exos might be optimal candidates for intravitreal injection, which could potentially overcome the obstacles and risks related to stem cell transplantation therapy, such as possible longterm pathological differentiation, vitreous opacities, and poor preservation [24] . In conclusion, we demonstrated that MSC-Exos exerted beneficial effects on the repair of blue light-induced retinal laser injury. The downregulation of VEGF expression might be influenced by vital proteins or RNAs encapsulated in MSCExos. These results suggested that the transplantation of MSC-Exos might act as a putative therapeutic tool to protect the retina. In future studies, we will examine the safety of this procedure in large animal models that closely mimic the human eye in order to better understand the direct relationship between the constituents of MSC-Exos and VEGF regulation.
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